Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Orally Disintegration Tablet Excipient Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Orally Disintegration Tablet Excipient Market Status and Forecast (2016-2027)
      • 1.3.2 Global Orally Disintegration Tablet Excipient Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Orally Disintegration Tablet Excipient Supply by Company

    • 2.1 Global Orally Disintegration Tablet Excipient Sales Volume by Company
    • 2.2 Global Orally Disintegration Tablet Excipient Sales Value by Company
    • 2.3 Global Orally Disintegration Tablet Excipient Price by Company
    • 2.4 Orally Disintegration Tablet Excipient Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Orally Disintegration Tablet Excipient Market Status by Category

    • 3.1 Orally Disintegration Tablet Excipient Category Introduction
      • 3.1.1 Binders
      • 3.1.2 Glidents
      • 3.1.3 Diluents
      • 3.1.4 Disintegrants
      • 3.1.5 Others
    • 3.2 Global Orally Disintegration Tablet Excipient Market by Category
      • 3.2.1 Global Orally Disintegration Tablet Excipient Sales Volume by Category (2016-2021)
      • 3.2.2 Global Orally Disintegration Tablet Excipient Sales Value by Category (2016-2021)
      • 3.2.3 Global Orally Disintegration Tablet Excipient Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Orally Disintegration Tablet Excipient Market Status by End User/Segment

    • 4.1 Orally Disintegration Tablet Excipient Segment by End User/Segment
      • 4.1.1 Anti-Psychotics Drug
      • 4.1.2 Anti-Epileptics Drug
      • 4.1.3 Others
    • 4.2 Global Orally Disintegration Tablet Excipient Market by End User/Segment
      • 4.2.1 Global Orally Disintegration Tablet Excipient Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Orally Disintegration Tablet Excipient Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Orally Disintegration Tablet Excipient Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Orally Disintegration Tablet Excipient Market Status by Region

    • 5.1 Global Orally Disintegration Tablet Excipient Market by Region
      • 5.1.1 Global Orally Disintegration Tablet Excipient Sales Volume by Region
      • 5.1.2 Global Orally Disintegration Tablet Excipient Sales Value by Region
    • 5.2 North America Orally Disintegration Tablet Excipient Market Status
    • 5.3 Europe Orally Disintegration Tablet Excipient Market Status
    • 5.4 Asia Pacific Orally Disintegration Tablet Excipient Market Status
    • 5.5 Central & South America Orally Disintegration Tablet Excipient Market Status
    • 5.6 Middle East & Africa Orally Disintegration Tablet Excipient Market Status

    6 North America Orally Disintegration Tablet Excipient Market Status

    • 6.1 North America Orally Disintegration Tablet Excipient Market by Country
      • 6.1.1 North America Orally Disintegration Tablet Excipient Sales Volume by Country (2016-2021)
      • 6.1.2 North America Orally Disintegration Tablet Excipient Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Orally Disintegration Tablet Excipient Market Status

    • 7.1 Europe Orally Disintegration Tablet Excipient Market by Country
      • 7.1.1 Europe Orally Disintegration Tablet Excipient Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Orally Disintegration Tablet Excipient Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Orally Disintegration Tablet Excipient Market Status

    • 8.1 Asia Pacific Orally Disintegration Tablet Excipient Market by Country
      • 8.1.1 Asia Pacific Orally Disintegration Tablet Excipient Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Orally Disintegration Tablet Excipient Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Orally Disintegration Tablet Excipient Market Status

    • 9.1 Central & South America Orally Disintegration Tablet Excipient Market by Country
      • 9.1.1 Central & South America Orally Disintegration Tablet Excipient Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Orally Disintegration Tablet Excipient Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Orally Disintegration Tablet Excipient Market Status

    • 10.1 Middle East & Africa Orally Disintegration Tablet Excipient Market by Country
      • 10.1.1 Middle East & Africa Orally Disintegration Tablet Excipient Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Orally Disintegration Tablet Excipient Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Orally Disintegration Tablet Excipient Distributors
    • 11.3 Orally Disintegration Tablet Excipient Buyers

    12 Global Orally Disintegration Tablet Excipient Market Forecast by Category and by End User/Segment

    • 12.1 Global Orally Disintegration Tablet Excipient Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Orally Disintegration Tablet Excipient Forecast by Category
      • 12.2.1 Global Orally Disintegration Tablet Excipient Sales Volume Forecast by Category
      • 12.2.2 Global Orally Disintegration Tablet Excipient Sales Value Forecast by Category
      • 12.2.3 Global Orally Disintegration Tablet Excipient Price Forecast by Category
    • 12.3 Global Orally Disintegration Tablet Excipient Forecast by End User/Segment
      • 12.3.1 Global Orally Disintegration Tablet Excipient Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Orally Disintegration Tablet Excipient Sales Value Forecast by End User/Segment
      • 12.3.3 Global Orally Disintegration Tablet Excipient Price Forecast by End User/Segment

    13 Global Orally Disintegration Tablet Excipient Market Forecast by Region/Country

    • 13.1 Global Orally Disintegration Tablet Excipient Market Forecast by Region (2022-2027)
      • 13.1.1 Global Orally Disintegration Tablet Excipient Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Orally Disintegration Tablet Excipient Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 BASF
      • 14.1.1 Company Information
      • 14.1.2 Orally Disintegration Tablet Excipient Product Introduction
      • 14.1.3 BASF Orally Disintegration Tablet Excipient Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 JRS Pharma
      • 14.2.1 Company Information
      • 14.2.2 Orally Disintegration Tablet Excipient Product Introduction
      • 14.2.3 JRS Pharma Orally Disintegration Tablet Excipient Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Meggle Pharma
      • 14.3.1 Company Information
      • 14.3.2 Orally Disintegration Tablet Excipient Product Introduction
      • 14.3.3 Meggle Pharma Orally Disintegration Tablet Excipient Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Ashland
      • 14.4.1 Company Information
      • 14.4.2 Orally Disintegration Tablet Excipient Product Introduction
      • 14.4.3 Ashland Orally Disintegration Tablet Excipient Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Fuji Chemical Industries
      • 14.5.1 Company Information
      • 14.5.2 Orally Disintegration Tablet Excipient Product Introduction
      • 14.5.3 Fuji Chemical Industries Orally Disintegration Tablet Excipient Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 DFE Pharma
      • 14.6.1 Company Information
      • 14.6.2 Orally Disintegration Tablet Excipient Product Introduction
      • 14.6.3 DFE Pharma Orally Disintegration Tablet Excipient Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 ABF Ingredients
      • 14.7.1 Company Information
      • 14.7.2 Orally Disintegration Tablet Excipient Product Introduction
      • 14.7.3 ABF Ingredients Orally Disintegration Tablet Excipient Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Anhui Sunhere Pharmaceutical
      • 14.8.1 Company Information
      • 14.8.2 Orally Disintegration Tablet Excipient Product Introduction
      • 14.8.3 Anhui Sunhere Pharmaceutical Orally Disintegration Tablet Excipient Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 McePharma (Vivesa holding)
      • 14.9.1 Company Information
      • 14.9.2 Orally Disintegration Tablet Excipient Product Introduction
      • 14.9.3 McePharma (Vivesa holding) Orally Disintegration Tablet Excipient Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Evonik
      • 14.10.1 Company Information
      • 14.10.2 Orally Disintegration Tablet Excipient Product Introduction
      • 14.10.3 Evonik Orally Disintegration Tablet Excipient Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Cargill Incorporated
    • 14.12 Roquette
    • 14.13 Merck KGaA
    • 14.14 Shin-Etsu
    • 14.15 Daicel Corporation

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Orally Disintegration Tablet Excipient market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Orally Disintegration Tablet Excipient market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Binders
    Glidents
    Diluents
    Disintegrants
    Others

    Segmented by End User/Segment
    Anti-Psychotics Drug
    Anti-Epileptics Drug
    Others

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    BASF
    JRS Pharma
    Meggle Pharma
    Ashland
    Fuji Chemical Industries
    DFE Pharma
    ABF Ingredients
    Anhui Sunhere Pharmaceutical
    McePharma (Vivesa holding)
    Evonik
    Cargill Incorporated
    Roquette
    Merck KGaA
    Shin-Etsu
    Daicel Corporation
    Buy now